Literature DB >> 19110624

Retroviral gene transfer into primary human natural killer cells.

Evren Alici1, Tolga Sutlu, M Sirac Dilber.   

Abstract

Modulation of intracellular signaling pathways or receptor expression in natural killer (NK) cells by genetic manipulation is an attractive possibility in studies of NK cell specificity and function. Moreover, feasible applications of these genetic manipulations in the context of gene and NK cell therapy regimens may be considered. However, efficient gene modification of primary NK cells has been largely hampered by the absence of an efficient gene-transfer protocol.A retrovirus-based easy-to-use transduction protocol that can insert the gene of interest permanently into primary NK cells would be an important tool to advance our studies in NK cell biology and NK cell-mediated therapies. We have recently described a protocol for efficient expansion of NK cells under good manufacturing practice (GMP) conditions from the healthy donors and from patients with hematological malignancies. As the active division of cells is a prerequisite for efficient retroviral insertion, the high rate of expansion in this protocol provides more efficient transduction by retroviral vectors. We hereby present this simple and efficient retroviral vector-based gene-transfer protocol for such ex vivo cultured primary human NK cells.

Entities:  

Mesh:

Year:  2009        PMID: 19110624     DOI: 10.1007/978-1-59745-409-4_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Natural killer cell engineering for cellular therapy of cancer.

Authors:  D R Shook; D Campana
Journal:  Tissue Antigens       Date:  2011-12

2.  Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy.

Authors:  Tolga Sutlu; Sanna Nyström; Mari Gilljam; Birgitta Stellan; Steven E Applequist; Evren Alici
Journal:  Hum Gene Ther       Date:  2012-09-10       Impact factor: 5.695

3.  Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins.

Authors:  Meisam Naeimi Kararoudi; Hamid Dolatshad; Prashant Trikha; Syed-Rehan A Hussain; Ezgi Elmas; Jennifer A Foltz; Jena E Moseman; Aarohi Thakkar; Robin J Nakkula; Margaret Lamb; Nitin Chakravarti; K John McLaughlin; Dean A Lee
Journal:  J Vis Exp       Date:  2018-06-14       Impact factor: 1.355

Review 4.  Bringing natural killer cells to the clinic: ex vivo manipulation.

Authors:  Richard W Childs; Maria Berg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

Review 5.  Engineered NK Cells Against Cancer and Their Potential Applications Beyond.

Authors:  Maria Karvouni; Marcos Vidal-Manrique; Andreas Lundqvist; Evren Alici
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

Review 6.  Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.

Authors:  Carin I M Dahlberg; Dhifaf Sarhan; Michael Chrobok; Adil D Duru; Evren Alici
Journal:  Front Immunol       Date:  2015-11-30       Impact factor: 7.561

Review 7.  Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies.

Authors:  Sandro Matosevic
Journal:  J Immunol Res       Date:  2018-09-17       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.